Gewirtz, Andrew T.

TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage

Carvalho, F. A., Aitken, J. D., Gewirtz, A. T., & Vijay-Kumar, M. (2011) · Mucosal Immunology

Immune Response and InflammationInflammasome and immune disorders

Cited by 80

Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis

Chandrasekharan, B., Bala, V., Kolachala, V. L., Vijay-Kumar, M., Jones, D., Gewirtz, A. T., Sitaraman, S. V., & Srinivasan, S. (2008) · PLoS ONE

Inflammatory Bowel DiseaseNeuropeptides and Animal Physiology

Cited by 70

How diet can impact gut microbiota to promote or endanger health

Chassaing, B., Vijay-Kumar, M., & Gewirtz, A. T. (2017) · Current Opinion in Gastroenterology

Gut microbiota and healthNutritional Studies and Diet

Cited by 52

Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study

Fedirko, V., Tran, H. Q., Gewirtz, A. T., Stepien, M., Trichopoulou, A., Aleksandrova, K., Olsen, A., Tjønneland, A., Overvad, K., Carbonnel, F., et al. (2017) · BMC Medicine

Hepatocellular Carcinoma Treatment and PrognosisGut microbiota and health

Cited by 50

Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome's potential to cause inflammation

Leifer, C. A., McConkey, C., Li, S., Chassaing, B., Gewirtz, A. T., & Ley, R. E. (2014) · Immunology Letters

Immune Response and InflammationGut microbiota and health

Cited by 34

Serum endotoxins and flagellin and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

Kong, S. Y., Tran, H. Q., Gewirtz, A. T., McKeown-Eyssen, G., Fedirko, V., Romieu, I., Tjønneland, A., Olsen, A., Overvad, K., Boutron-Ruault, M.-C., et al. (2016) · Cancer Epidemiology, Biomarkers & Prevention

Gut microbiota and healthColorectal Cancer Screening and Detection

Cited by 34

In vitro microbiota model recapitulates and predicts individualised sensitivity to dietary emulsifier

Rytter, H., Naimi, S., Wu, G., Lewis, J., Duquesnoy, M., Vigué, L., Tenaillon, O., Belda, E., Vazquez-Gomez, M., Touly, N., et al. (2025) · Gut

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 19

Human Intestinal Microbiome Determines Individualized Inflammatory Response to Dietary Emulsifier Carboxymethylcellulose Consumption

Daniel, N., Wu, G. D., Walters, W., Compher, C., Ni, J., Delaroque, C., Albenberg, L., Ley, R. E., Patterson, A. D., Lewis, J. D., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 14